Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-104550
Filing Date
2025-08-07
Accepted
2025-08-07 07:06:08
Documents
85
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glue-20250630.htm   iXBRL 10-Q 2569462
2 EX-31.1 glue-ex31_1.htm EX-31.1 19021
3 EX-32.1 glue-ex32_1.htm EX-32.1 11544
  Complete submission text file 0000950170-25-104550.txt   10451389

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT glue-20250630.xsd EX-101.SCH 1253413
87 EXTRACTED XBRL INSTANCE DOCUMENT glue-20250630_htm.xml XML 2132413
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)